Skip to main content
Access Resources

MJFF Publications

4251 - 4260 of 7540 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • RESTRICTED
    Title: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease
    Journal Name: European Journal of Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914
    Best OA location URL:
    Citation Count: 13
  • RESTRICTED
    Title: Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
    Journal Name: Clinical Cancer Research
    Publisher: American Association for Cancer Research (AACR)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1158/1078-0432.ccr-19-1376
    Citation Count: 147
  • RESTRICTED
    Title: Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-020-0755-1
    Citation Count: 642
  • RESTRICTED
    Title: Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson’s disease
    Journal Name: Artificial Intelligence in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.artmed.2020.101807
    Best OA location URL:
    Citation Count: 21
  • RESTRICTED
    Title: Social Impact of Connected Landmark Lighting: A Social Sensing Approach
    Journal Name: IEEE Internet of Things Magazine
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/iotm.0001.1900088
    Best OA location URL:
    Citation Count: 1
  • RESTRICTED
    Title: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983
    Best OA location URL:
    Citation Count: 11
  • RESTRICTED
    Title: Three-Plane–assembled Deep Learning Segmentation of Gliomas
    Journal Name: Radiology: Artificial Intelligence
    Publisher: Radiological Society of North America (RSNA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1148/ryai.2020190011
    Citation Count: 17
  • RESTRICTED
    Title: β-adrenoreceptors and the risk of Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4
    Best OA location URL:
    Citation Count: 44
  • RESTRICTED
    Title: An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells9030576
    Citation Count: 20
  • RESTRICTED
    Title: Outcome measurement in functional neurological disorder: a systematic review and recommendations
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/jnnp-2019-322180
    Citation Count: 74
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.